In part two of our special focus on the pulmonary embolism (PE) treatment landscape, Patrick Muck (Good Samaritan Hospital, Cincinnati, USA) is joined by John Moriarty (UCLA Health, Los Angeles, USA) and Robert Lookstein (Mount Sinai, New York, USA) to dive deeper into therapies, the research and data behind them, and what’s coming next further down the road as the space continues to evolve apace.
Watch the first installment—“From no data to a lot of data quickly”—here.
